While medullary thyroid cancer remains a surgically treated malignancy, the opportunity for cure is dependent on early diagnosis and treatment. After a brief review of current treatment guidelines, panelists will participate in a semi-structured case-based discussion of disease management focusing on areas of critical importance to management and those that remain controversial.
Join us for a robust discussion based CME with representation from a multidisciplinary team of specialists from endocrinology, pathology and laboratory, medical oncology and surgical oncology.
Moderator: Susan J. Mandel, MD, MPH
Virginia LiVolsi, MD
Kate Nathanson, MD
Lova L. Sun, MD, MSCE
Rachel Kelz, MD, MBA
After participating in this activity, the learner should be able to:
1. Describe the diagnostic evaluation for a patient diagnosed with medullary thyroid cancer
2. Explain principles of appropriate surgical management
3. Discuss evidence-based surveillance strategies
4. Review the indications for systemic therapy
In support of improving patient care, Penn Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physicians: Penn Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.